World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
36862
World Ranking
7688
National Ranking
752

Overview

Julian D. Gillmore is affiliated with University College London in the United Kingdom and has contributed extensively to research primarily in medicine and biochemistry, genetics, and molecular biology. Their work spans various topics with a focus on amyloidosis, its diagnosis, treatment, and outcomes.

Their recent publications include significant articles such as:

  • CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis (2021), published in New England Journal of Medicine
  • Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy (2024), published in New England Journal of Medicine

These papers reflect ongoing research into transthyretin amyloidosis and related therapeutic interventions.

Frequent coauthors in Gillmore's work include:

  • Philip N. Hawkins
  • Marianna Fontana
  • Helen J. Lachmann
  • Carol Whelan
  • Ana Martinez-Naharro

Publication venues where Gillmore's research regularly appears include:

  • Journal of the American College of Cardiology
  • Circulation
  • European Heart Journal
  • Amyloid
  • European Journal of Heart Failure

Gillmore's research fields highlight a multidisciplinary approach combining medicine with molecular biology, nephrology, genetics, rheumatology, and oncology. Subfields of particular emphasis are molecular biology, nephrology, and genetics.

Main topics covered in their research are broad, including:

  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Parathyroid Disorders and Treatments
  • Eosinophilic Disorders and Syndromes
  • Peptidase Inhibition and Analysis
  • Medical Imaging and Pathology Studies
  • Neuroendocrine Tumor Research Advances
  • Protein Kinase Regulation and GTPase Signaling

Besides journal articles, Gillmore has contributed to academic books such as the 2023 publication "Proceedings and Predictions in Cardiac Amyloidosis: Unsolved mysteries and challenges for the future," published by Frontiers Media.

Best Publications

  • Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

    Julian D. Gillmore;Mathew S. Maurer;Rodney H. Falk;Giampaolo Merlini

  • CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

    Julian D. Gillmore;Ed Gane;Jorg Taubel;Justin Kao

  • Natural history and outcome in systemic AA amyloidosis.

    Helen J Lachmann;Hugh J B Goodman;Janet A Gilbertson;J Ruth Gallimore

  • Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.

    Helen J Lachmann;David R Booth;Susanne E Booth;Alison Bybee

  • Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

    Pablo Garcia-Pavia;Claudio Rapezzi;Yehuda Adler;Michael Arad

  • Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.

    Julian D Gillmore;Laurence B Lovat;Malcolm R Persey;Mark B Pepys

  • ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2—Evidence Base and Standardized Methods of Imaging

    Sharmila Dorbala;Yukio Ando;Sabahat Bokhari;Angela Dispenzieri

  • Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis

    Marianna Fontana;Silvia Pica;Patricia Reant;Amna Abdel-Gadir

  • A new staging system for cardiac transthyretin amyloidosis

    Julian D Gillmore;Thibaud Damy;Marianna Fontana;Matthew Hutchinson

  • Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy.

    Helen J. Lachmann;Ruth Gallimore;Julian D. Gillmore;Hugh D. Carr-Smith

  • A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis

    Ashutosh D. Wechalekar;Stefan O. Schonland;Efstathios Kastritis;Julian D. Gillmore

  • The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

    Nelson Leung;Frank Bridoux;Vecihi Batuman;Aristeidis Chaidos

  • Native T1 mapping in transthyretin amyloidosis

    Marianna Fontana;Sanjay M. Banypersad;Thomas A. Treibel;Viviana Maestrini

  • A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis.

    Giovanni Palladini;Sajitha Sachchithanantham;Paolo Milani;Julian Gillmore

  • Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome

    Jennifer H. Pinney;Carol J. Whelan;Aviva Petrie;Jason Dungu;Jason Dungu

  • T1 mapping and survival in systemic light-chain amyloidosis

    Sanjay M. Banypersad;Sanjay M. Banypersad;Marianna Fontana;Viviana Maestrini;Daniel M. Sado

  • Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis.

    Thirusha Lane;Marianna Fontana;Ana Martinez-Naharro;Candida Cristina Quarta

  • Magnetic Resonance in Transthyretin Cardiac Amyloidosis.

    Ana Martinez-Naharro;Thomas A. Treibel;Amna Abdel-Gadir;Heerajnarain Bulluck

  • Antibodies to human serum amyloid P component eliminate visceral amyloid deposits

    Karl Bodin;Stephan Ellmerich;Melvyn C. Kahan;Glenys A. Tennent

  • Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component

    Duncan B. Richards;Louise M. Cookson;Alienor C. Berges;Sharon V. Barton

Frequent Co-Authors

Helen J. Lachmann
Helen J. Lachmann University College London
James C. Moon
James C. Moon University College London
Philip N. Hawkins
Philip N. Hawkins University College London
Mark B. Pepys
Mark B. Pepys University College London
Giampaolo Merlini
Giampaolo Merlini University of Pavia
Vittorio Bellotti
Vittorio Bellotti University College London
Mathew S. Maurer
Mathew S. Maurer Columbia University
Rodney H. Falk
Rodney H. Falk Brigham and Women's Hospital
Efstathios Kastritis
Efstathios Kastritis National and Kapodistrian University of Athens

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Medicine but seeking alternative or complementary career paths, there are a variety of flexible online degree programs that can open doors in healthcare. Roles in healthcare administration, nutrition, and nursing leadership are just some of the many healthcare careers with strong demand across the USA.

An excellent starting point for leadership and management roles is a healthcare administration associate degree online. This program prepares students for entry-level administrative positions in hospitals, clinics, and other care facilities.

If you are already a registered nurse, adn to msn bridge programs online offer a fast track to advanced practice, teaching, or management roles within nursing. Similarly, a bachelor's in nutrition online can equip you to become a nutritionist, dietitian, or wellness consultant—crucial roles in preventative health and patient care.

For those aiming for higher-level administrative roles, a cahme accredited online mha (Master of Health Administration) degree is widely respected and geared toward future healthcare executives.

These online degrees offer the flexibility to study while working, and enable career advancement across various facets of the healthcare sector.

Best Scientists Citing Julian D. Gillmore

Trending Scientists